Homocysteine References
1. Genest JJ, Jr., McNamara JR, Salem DN, et al. Plasma
homocyst(e)ine levels in men with premature coronary artery
disease. J Am Coll Cardiol. 1990 Nov;16(5):1114-9.
2. Clarke R, Daly L, Robinson K, et al. Hyperhomocysteinemia: an
independent risk factor for vascular disease. N Engl J Med. 1991
Apr 25;324(17):1149-55.
3. Taylor LM, Jr., DeFrang RD, Harris EJ, Jr., Porter JM. The
association of elevated plasma homocyst(e)ine with progression
of symptomatic peripheral arterial disease. J Vasc Surg. 1991
Jan;13(1):128-36.
4. Stampfer MJ, Malinow MR, Willett WC, et al. A prospective
study of plasma homocyst(e)ine and risk of myocardial infarction
in US physicians. JAMA. 1992 Aug 19;268(7):877-81.
5. Brattstrom L, Lindgren A, Israelsson B, et al.
Hyperhomocysteinaemia in stroke: prevalence, cause, and
relationships to type of stroke and stroke risk factors. Eur J
Clin Invest. 1992 Mar;22(3):214-21.
6. Fryer RH, Wilson BD, Gubler DB, Fitzgerald LA, Rodgers GM.
Homocysteine, a risk factor for premature vascular disease and
thrombosis, induces tissue factor activity in endothelial cells.
Arterioscler Thromb. 1993 Sep;13(9):1327-33.
7. Hajjar KA. Homocysteine-induced modulation of tissue
plasminogen activator binding to its endothelial cell membrane
receptor. J Clin Invest. 1993 Jun;91(6):2873-9.
8. Pancharuniti N, Lewis CA, Sauberlich HE, et al. Plasma
homocyst(e)ine, folate, and vitamin B-12 concentrations and risk
for early-onset coronary artery disease. Am J Clin Nutr. 1994
Apr;59(4):940-8.
9. Selhub J, Jacques PF, Bostom AG, et al. Association between
plasma homocysteine concentrations and extracranial
carotid-artery stenosis. N Engl J Med. 1995 Feb 2;332(5):286-91.
10. Glueck CJ, Shaw P, Lang JE, et al. Evidence that
homocysteine is an independent risk factor for atherosclerosis
in hyperlipidemic patients. Am J Cardiol. 1995 Jan
15;75(2):132-6.
11. Arnesen E, Refsum H, Bonaa KH, et al. Serum total
homocysteine and coronary heart disease. Int J Epidemiol. 1995
Aug;24(4):704-9.
12. Mills JL, McPartlin JM, Kirke PN, et al. Homocysteine
metabolism in pregnancies complicated by neural-tube defects.
Lancet. 1995 Jan 21;345(8943):149-51.
13. Steegers-Theunissen RP, Boers GH, Blom HJ, et al. Neural
tube defects and elevated homocysteine levels in amniotic fluid.
Am J Obstet Gynecol. 1995 May;172(5):1436-41.
14. Tonstad S, Joakimsen O, Stensland-Bugge E, et al. Risk
factors related to carotid intima-media thickness and plaque in
children with familial hypercholesterolemia and control
subjects. Arterioscler Thromb Vasc Biol. 1996 Aug;16(8):984-91.
15. Tonstad S, Refsum H, Sivertsen M, et al. Relation of total
homocysteine and lipid levels in children to premature
cardiovascular death in male relatives. Pediatr Res. 1996
Jul;40(1):47-52.
16. Gallagher PM, Meleady R, Shields DC, et al. Homocysteine and
risk of premature coronary heart disease. Evidence for a common
gene mutation. Circulation. 1996 Nov 1;94(9):2154-8.
17. Mills JL, Scott JM, Kirke PN, et al. Homocysteine and neural
tube defects. J Nutr. 1996 Mar;126(3):756S-60S.
18. Graham IM, Daly LE, Refsum HM, et al. Plasma homocysteine as
a risk factor for vascular disease. The European Concerted
Action Project. JAMA. 1997 Jun 11;277(22):1775-81.
19. Verhoef P, Kok FJ, Kruyssen DA, et al. Plasma total
homocysteine, B vitamins, and risk of coronary atherosclerosis.
Arterioscler Thromb Vasc Biol. 1997 May;17(5):989-95.
20. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma
homocysteine levels and mortality in patients with coronary
artery disease. N Engl J Med. 1997 Jul 24;337(4):230-6.
21. Hoogeveen EK, Kostense PJ, Beks PJ, et al.
Hyperhomocysteinemia is associated with an increased risk of
cardiovascular disease, especially in non-insulin-dependent
diabetes mellitus: a population-based study. Arterioscler Thromb
Vasc Biol. 1998 Jan;18(1):133-8.
22. Refsum H, Ueland PM, Nygard O, Vollset SE. Homocysteine and
cardiovascular disease. Annu Rev Med. 1998;49:31-62.
23. Stehouwer CD, Weijenberg MP, van den BM, et al. Serum
homocysteine and risk of coronary heart disease and
cerebrovascular disease in elderly men: a 10-year follow-up.
Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1895-901.
24. Wald NJ, Watt HC, Law MR, et al. Homocysteine and ischemic
heart disease: results of a prospective study with implications
regarding prevention. Arch Intern Med. 1998 Apr 27;158(8):862-7.
25. Scott CH, Sutton MS. Homocysteine: evidence for a causal
relationship with cardiovascular disease. Cardiol Rev. 1999
Mar;7(2):101-7.
26. Osganian SK, Stampfer MJ, Spiegelman D, et al. Distribution
of and factors associated with serum homocysteine levels in
children: Child and Adolescent Trial for Cardiovascular Health.
JAMA. 1999 Apr 7;281(13):1189-96.
27. Kato I, Dnistrian AM, Schwartz M, et al. Serum folate,
homocysteine and colorectal cancer risk in women: a nested
case-control study. Br J Cancer. 1999 Apr;79(11-12):1917-22.
28. Stone DH, McCarron P, Smith GD. Similarities in the
epidemiology of neural tube defects and coronary heart disease:
is homocysteine the missing link? J Epidemiol Community Health.
1999 Dec;53(12):789-93.
29. Temple ME, Luzier AB, Kazierad DJ. Homocysteine as a risk
factor for atherosclerosis. Ann Pharmacother. 2000
Jan;34(1):57-65.
30. Tribouilloy CM, Peltier M, Iannetta Peltier MC, et al.
Plasma homocysteine and severity of thoracic aortic
atherosclerosis. Chest. 2000 Dec;118(6):1685-9.
31. van GC, Robinson K. Homocysteine and renal disease. Semin
Thromb Hemost. 2000;26(3):313-24.
32. Thomson SW, Heimburger DC, Cornwell PE, et al. Effect of
total plasma homocysteine on cervical dysplasia risk. Nutr
Cancer. 2000;37(2):128-33.
33. Bottiglieri T, Laundy M, Crellin R, et al. Homocysteine,
folate, methylation, and monoamine metabolism in depression. J
Neurol Neurosurg Psychiatry. 2000 Aug;69(2):228-32.
34. Vollset SE, Refsum H, Irgens LM, et al. Plasma total
homocysteine, pregnancy complications, and adverse pregnancy
outcomes: the Hordaland Homocysteine study. Am J Clin Nutr. 2000
Apr;71(4):962-8.
35. Postiglione A, Milan G, Ruocco A, et al. Plasma folate,
vitamin B(12), and total homocysteine and homozygosity for the
C677T mutation of the 5,10-methylene tetrahydrofolate reductase
gene in patients with Alzheimer’s dementia. A case-control
study. Gerontology. 2001 Nov;47(6):324-9.
36. McCaddon A, Hudson P, Davies G, et al. Homocysteine and
cognitive decline in healthy elderly. Dement Geriatr Cogn Disord.
2001 Sep;12(5):309-13.
37. Weinstein SJ, Ziegler RG, Selhub J, et al. Elevated serum
homocysteine levels and increased risk of invasive cervical
cancer in US women. Cancer Causes Control. 2001
May;12(4):317-24.
38. Tice JA, Ross E, Coxson PG, et al. Cost-effectiveness of
vitamin therapy to lower plasma homocysteine levels for the
prevention of coronary heart disease: effect of grain
fortification and beyond. JAMA. 2001 Aug 22;286(8):936-43.
39. Cattaneo M, Lombardi R, Lecchi A, Bucciarelli P, Mannucci
PM. Low plasma levels of vitamin B(6) are independently
associated with a heightened risk of deep-vein thrombosis.
Circulation. 2001 Nov 13;104(20):2442-6.
40. Vollset SE, Refsum H, Tverdal A, et al. Plasma total
homocysteine and cardiovascular and noncardiovascular mortality:
the Hordaland Homocysteine Study. Am J Clin Nutr. 2001
Jul;74(1):130-6.
41. Seshadri S, Beiser A, Selhub J, et al. Plasma homocysteine
as a risk factor for dementia and Alzheimer’s disease. N Engl J
Med. 2002 Feb 14;346(7):476-83.
42. O’Callaghan P, Meleady R, Fitzgerald T, Graham I. Smoking
and plasma homocysteine. Eur Heart J. 2002 Oct;23(20):1580-6.
43. Anon. Homocysteine and risk of ischemic heart disease and
stroke: a meta-analysis. JAMA. 2002 Oct 23;288(16):2015-22.
44. Wald DS, Law M, Morris JK. Homocysteine and cardiovascular
disease: evidence on causality from a meta-analysis. BMJ. 2002
Nov 23;325(7374):1202.
45. De BA, Verschuren WM, Kromhout D, Kluijtmans LA, Blom HJ.
Homocysteine determinants and the evidence to what extent
homocysteine determines the risk of coronary heart disease.
Pharmacol Rev. 2002 Dec;54(4):599-618.
46. Morris MS. Homocysteine and Alzheimer’s disease. Lancet
Neurol. 2003 Jul;2(7):425-8.
47. Teunissen CE, Blom AH, Van Boxtel MP, et al. Homocysteine: a
marker for cognitive performance? A longitudinal follow-up
study. J Nutr Health Aging. 2003;7(3):153-9.
48. Morgenstern I, Raijmakers MT, Peters WH, Hoensch H, Kirch W.
Homocysteine, cysteine, and glutathione in human colonic mucosa:
elevated levels of homocysteine in patients with inflammatory
bowel disease. Dig Dis Sci. 2003 Oct;48(10):2083-90.
49. Clarke R, Lewington S, Landray M. Homocysteine, renal
function, and risk of cardiovascular disease. Kidney Int Suppl.
2003 May;(84):S131-3.
50. Tanne D, Haim M, Goldbourt U, et al. Prospective study of
serum homocysteine and risk of ischemic stroke among patients
with preexisting coronary heart disease. Stroke. 2003
Mar;34(3):632-6.
51. Warsi AA, Davies B, Morris-Stiff G, Hullin D, Lewis MH.
Abdominal aortic aneurysm and its correlation to plasma
homocysteine, and vitamins. Eur J Vasc Endovasc Surg. 2004
Jan;27(1):75-9.
52. Stanger O, Herrmann W, Pietrzik K, et al. Clinical use and
rational management of homocysteine, folic acid, and B vitamins
in cardiovascular and thrombotic diseases. Z Kardiol. 2004
Jun;93(6):439-53.
53. Wald DS, Law M, Morris JK. The dose-response relation
between serum homocysteine and cardiovascular disease:
implications for treatment and screening. Eur J Cardiovasc Prev
Rehabil. 2004 Jun;11(3):250-3.
54. Buccianti G, Baragetti I, Bamonti F, et al. Plasma
homocysteine levels and cardiovascular mortality in patients
with end-stage renal disease. J Nephrol. 2004 May;17(3):405-10.
55. Zylberstein DE, Bengtsson C, Bjorkelund C, et al. Serum
homocysteine in relation to mortality and morbidity from
coronary heart disease: a 24-year follow-up of the population
study of women in Gothenburg. Circulation. 2004 Feb
10;109(5):601-6.
56. Gillum RF. Distribution of total serum homocysteine and its
association with parental history and cardiovascular risk
factors at ages 12-16 years: the Third National Health And
Nutrition Examination Survey. Ann Epidemiol. 2004
Mar;14(3):229-33.
57. Scott TM, Tucker KL, Bhadelia A, et al. Homocysteine and B
vitamins relate to brain volume and white-matter changes in
geriatric patients with psychiatric disorders. Am J Geriatr
Psychiatry. 2004 Nov;12(6):631-8.
58. Quadri P, Fragiacomo C, Pezzati R, et al. Homocysteine,
folate, and vitamin B-12 in mild cognitive impairment, Alzheimer
disease, and vascular dementia. Am J Clin Nutr. 2004
Jul;80(1):114-22.
59. McLean RR, Jacques PF, Selhub J, et al. Homocysteine as a
predictive factor for hip fracture in older persons. N Engl J
Med. 2004 May 13;350(20):2042-9.
60. van Meurs JB, Dhonukshe-Rutten RA, Pluijm SM, et al.
Homocysteine levels and the risk of osteoporotic fracture. N
Engl J Med. 2004 May 13;350(20):2033-41.
61. Kado DM, Karlamangla AS, Huang MH, et al. Homocysteine
versus the vitamins folate, B6, and B12 as predictors of
cognitive function and decline in older high-functioning adults:
MacArthur Studies of Successful Aging. Am J Med. 2005
Feb;118(2):161-7.
62. Quadri P, Fragiacomo XC, Pezzati R, et al. Homocysteine and
B vitamins in mild cognitive impairment and dementia. Clin Chem
Lab Med. 2005;43(10):1096-100.
63. Sofi F, Marcucci R, Giusti B, et al. High levels of
homocysteine, lipoprotein (a) and plasminogen activator
inhibitor-1 are present in patients with abdominal aortic
aneurysm. Thromb Haemost. 2005 Nov;94(5):1094-8.
64. Rasouli ML, Nasir K, Blumenthal RS, et al. Plasma
homocysteine predicts progression of atherosclerosis.
Atherosclerosis. 2005 Jul;181(1):159-65.
65. Virtanen JK, Voutilainen S, Alfthan G, et al. Homocysteine
as a risk factor for CVD mortality in men with other CVD risk
factors: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD)
Study. J Intern Med. 2005 Mar;257(3):255-62.
66. Kuo HK, Yen CJ, Bean JF. Levels of homocysteine are
inversely associated with cardiovascular fitness in women, but
not in men: data from the National Health and Nutrition
Examination Survey 1999-2002. J Intern Med. 2005
Oct;258(4):328-35.
67. Robbins MA, Elias MF, Budge MM, Brennan SL, Elias PK.
Homocysteine, type 2 diabetes mellitus, and cognitive
performance: The Maine-Syracuse Study. Clin Chem Lab Med.
2005;43(10):1101-6.
68. Teunissen CE, Van Boxtel MP, Jolles J, et al. Homocysteine
in relation to cognitive performance in pathological and
non-pathological conditions. Clin Chem Lab Med.
2005;43(10):1089-95.
69. Schafer JH, Glass TA, Bolla KI, et al. Homocysteine and
cognitive function in a population-based study of older adults.
J Am Geriatr Soc. 2005 Mar;53(3):381-8.
70. Sachdev PS, Parslow RA, Lux O, et al. Relationship of
homocysteine, folic acid and vitamin B12 with depression in a
middle-aged community sample. Psychol Med. 2005
Apr;35(4):529-38.
71. Kamburoglu G, Gumus K, Kadayifcilar S, Eldem B. Plasma
homocysteine, vitamin B12 and folate levels in age-related
macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2006
May;244(5):565-9.
72. Nowak M, Swietochowska E, Wielkoszynski T, et al.
Homocysteine, vitamin B12, and folic acid in age-related macular
degeneration. Eur J Ophthalmol. 2005 Nov;15(6):764-7.
73. Levine J, Sela BA, Osher Y, Belmaker RH. High homocysteine
serum levels in young male schizophrenia and bipolar patients
and in an animal model. Prog Neuropsychopharmacol Biol
Psychiatry. 2005 Sep;29(7):1181-91.
74. Herrmann M, Widmann T, Herrmann W. Homocysteine—a newly
recognised risk factor for osteoporosis. Clin Chem Lab Med.
2005;43(10):1111-7.
75. Dhonukshe-Rutten RA, Pluijm SM, de Groot LC, et al.
Homocysteine and vitamin B12 status relate to bone turnover
markers, broadband ultrasound attenuation, and fractures in
healthy elderly people. J Bone Miner Res. 2005 Jun;20(6):921-9.
76. Sato Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine as a
predictive factor for hip fracture in elderly women with
Parkinson’s disease. Am J Med. 2005 Nov;118(11):1250-5.
77. Sato Y, Honda Y, Iwamoto J, Kanoko T, Satoh K. Homocysteine
as a predictive factor for hip fracture in stroke patients.
Bone. 2005 Apr;36(4):721-6.
78. Picker JD, Coyle JT. Do maternal folate and homocysteine
levels play a role in neurodevelopmental processes that increase
risk for schizophrenia? Harv Rev Psychiatry. 2005
Jul;13(4):197-205.
79. Virtanen JK, Voutilainen S, Happonen P, et al. Serum
homocysteine, folate and risk of stroke: Kuopio Ischaemic Heart
Disease Risk Factor (KIHD) Study. Eur J Cardiovasc Prev Rehabil.
2005 Aug;12(4):369-75.
80. Kullo IJ, Li G, Bielak LF, et al. Association of plasma
homocysteine with coronary artery calcification in different
categories of coronary heart disease risk. Mayo Clin Proc. 2006
Feb;81(2):177-82.
81. Nerbass FB, Draibe SA, Feiten SF, et al. Homocysteine and
its determinants in nondialyzed chronic kidney disease patients.
J Am Diet Assoc. 2006 Feb;106(2):267-70.
82. Seddon JM, Gensler G, Klein ML, Milton RC. Evaluation of
plasma homocysteine and risk of age-related macular
degeneration. Am J Ophthalmol. 2006 Jan;141(1):201-3.
83. Gjesdal CG, Vollset SE, Ueland PM, et al. Plasma total
homocysteine level and bone mineral density: the Hordaland
Homocysteine Study. Arch Intern Med. 2006 Jan 9;166(1):88-94.
84. Levine J, Stahl Z, Sela BA, et al. Homocysteine-reducing
strategies improve symptoms in chronic schizophrenic patients
with hyperhomocysteinemia. Biol Psychiatry. 2006 Jan 17.
85. Muntjewerff JW, Kahn RS, Blom HJ, den HM. Homocysteine,
methylenetetrahydrofolate reductase and risk of schizophrenia: a
meta-analysis. Mol Psychiatry. 2006 Feb;11(2):143-9.
